Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Although Mdm2-mediated ubiquitination is essential for both degradation and nuclear export of p53, the molecular basis for the differential effects of Mdm2 remains unknown. Here we show that low levels of Mdm2 activity induce monoubiquitination and nuclear export of p53, whereas high levels promote p53's polyubiquitination and nuclear degradation. A p53-ubiquitin fusion protein that mimics monoubiquitinated p53 was found to accumulate in the cytoplasm in an Mdm2-independent manner, indicating that monoubiquitination is critical for p53 trafficking. These results clarify the nature of ubiquitination-mediated p53 regulation and suggest that distinct mechanisms regulate p53 function in accordance with the levels of Mdm2 activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“proteasome inhibition by ALLN stabilizes p53 mainly in the nucleus of RKO cancer cells, whereas cytoplasmic p53 accumulates to a far lower extent”
From Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding (2010) · cites this paper as [23]
In the citing paper
“Interestingly, although p53 nuclear import is negatively regulated by ubiquitin modification, p53 nuclear export as well as translocation of cytoplasmic p53 to mitochondria are positively regulated by ubiquitin.23,37,38”
From Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding (2010) · cites this paper as [23]
In the citing paper
“Interestingly, although p53 nuclear import is negatively regulated by ubiquitin modification, p53 nuclear export as well as translocation of cytoplasmic p53 to mitochondria are positively regulated by ubiquitin.23,37,38”
From Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding (2010) · cites this paper as [23]
In the citing paper
“Additionally, mono-ubiquitination of p53 can facilitate export of p53 from the nucleus to the cytoplasm, thereby inhibiting its role as a transcription factor [110,111].”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [111]
In the citing paper
“However, proteasome-dependent degradation of nuclear p53 can also effectively prevent its transactivation function [111,112], suggesting monoubiquitylation of cytoplasmic p53 is required for other processes.”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [111]
Citations
Cites
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Mechanisms Underlying Ubiquitination
Pickart, C. M. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.503 · Cited by 3,184
Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Mdm2 Is a RING Finger-dependent Ubiquitin Protein Ligase for Itself and p53
Fang, S., Jensen, J. P., Ludwig, R. L., Vousden, K. H., & Weissman, A. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8945 · Cited by 1,044
Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization
Li, M., Chen, D., Shiloh, A., Luo, J., Nikolaev, A. Y., Qin, J., & Gu, W. (2002) · Nature · doi:10.1038/nature737 · Cited by 1,031
Self-citationStommel, J. M., Marchenko, N. D., Jimenez, G. S., Moll, U. M., Hope, T. J., & Wahl, G. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1660 · Cited by 738
Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 Degradation
Leng, R. P., Lin, Y., Ma, W., Wu, H., Lemmers, B., Chung, S., Parant, J. M., Lozano, G., Hakem, R., & Benchimol, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00193-4 · Cited by 722
Generation of oscillations by the p53-Mdm2 feedback loop: A theoretical and experimental study
Lev Bar-Or, R., Maya, R., Segel, L. A., Alon, U., Levine, A. J., & Oren, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.210171597 · Cited by 588
Cited by
Items 101–200 of 797
Yadavilli, S., Mayo, L. D., Higgins, M., Lain, S., Hegde, V., & Deutsch, W. A. (2009) · DNA Repair · doi:10.1016/j.dnarep.2009.07.003 · Cited by 154
Proteasome activator PA28γ regulates p53 by enhancing its MDM2-mediated degradation
Zhang, Z., & Zhang, R. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.25 · Cited by 153
“We utilized a previously described protocol to evaluate ubiquitination (Li et al, 2003).”
BackgroundMethodInfluentialHsp90 Chaperones Wild-type p53 Tumor Suppressor Protein
Walerych, D., Kudla, G., Gutkowska, M., Wawrzynow, B., Muller, L., King, F. W., Helwak, A., Boros, J., Zylicz, A., & Zylicz, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407601200 · Cited by 154
Yu, J. Q., Tao, Q., Cheung, K. F., Jin, H., Poon, F. F., Wang, X., Li, H., Cheng, Y. Y., Röcken, C., Ebert, M. P. A., et al. (2008) · Hepatology · doi:10.1002/hep.22343 · Cited by 163
20S Proteasomal Degradation of Ornithine Decarboxylase Is Regulated by NQO1
Asher, G., Bercovich, Z., Tsvetkov, P., Shaul, Y., & Kahana, C. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.01.020 · Cited by 165
Wang, Y. E., Park, A., Lake, M., Pentecost, M., Torres, B., Yun, T., Wolf, M. C., Holbrook, M. R., Freiberg, A. N., & Lee, B. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001186 · Cited by 154
The C terminus of p53 binds the N-terminal domain of MDM2
Poyurovsky, M. V., Katz, C., Laptenko, O., Beckerman, R., Lokshin, M., Ahn, J., Byeon, I.-J. L., Gabizon, R., Mattia, M., Zupnick, A., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1872 · Cited by 149
Lindstroöm, M. S., Jin, A., Deisenroth, C., White Wolf, G., & Zhang, Y. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01307-06 · Cited by 152
“It was demonstrated that low levels of MDM2 mediate p53 monoubiquitination and preferentially target p53 for export to the cytoplasm, whereas high levels of MDM2 lead to p53 polyubiquitination and degradation in both the nucleus and the cytoplasm ( 30 ).”
BackgroundLatonen, L., Moore, H. M., Bai, B., Jäämaa, S., & Laiho, M. (2010) · Oncogene · doi:10.1038/onc.2010.469 · Cited by 153
Kalia, L. V., Kalia, S. K., Chau, H., Lozano, A. M., Hyman, B. T., & McLean, P. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014695 · Cited by 157
“. Monoubiquitinylation has also been found to act as a nuclear export signal”
BackgroundAn E3 ligase guide to the galaxy of small-molecule-induced protein degradation
Jevtić, P., Haakonsen, D. L., & Rapé, M. (2021) · Cell Chemical Biology · doi:10.1016/j.chembiol.2021.04.002 · Cited by 143
Wwp2, an E3 Ubiquitin Ligase That Targets Transcription Factor Oct-4 for Ubiquitination
Xu, H. M., Liao, B., Zhang, Q. J., Wang, B. B., Li, H., Zhong, X. M., Sheng, H. Z., Zhao, Y. X., Zhao, Y. M., & Jin, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400516200 · Cited by 142
Adaptor Protein Self-Assembly Drives the Control of a Cullin-RING Ubiquitin Ligase
Errington, W. J., Khan, M. Q., Bueler, S. A., Rubinstein, J. L., Chakrabartty, A., & Privé, G. G. (2012) · Structure · doi:10.1016/j.str.2012.04.009 · Cited by 150
“Mdm2, for example, through a concentration dependent mechanism, is capable of directing p53 to either the proteasome or for nuclear export (Li et al., 2003).”
BackgroundRegulation of p53: a collaboration between Mdm2 and MdmX
Pei, D., Zhang, Y., & Zheng, J. (2012) · Oncotarget · doi:10.18632/oncotarget.443 · Cited by 140
Stabilization of E2F1 protein by MDM2 through the E2F1 ubiquitination pathway
Zhang, Z., Wang, H., Li, M., Rayburn, E. R., Agrawal, S., & Zhang, R. (2005) · Oncogene · doi:10.1038/sj.onc.1208814 · Cited by 162
“Moreover, upon binding to p53, MDM2 shuttles the p53 protein from the nucleus into the cytoplasm, where it facilitates its ubiquitination and subsequent degradation by the proteasome (Chen et al., 1993; Freedman and Levine, 1998; Fuchs et al., 1998; Li et al., 2003).”
BackgroundThe p53 protein family and radiation sensitivity: Yes or no?
Cuddihy, A. R., & Bristow, R. G. (2004) · Cancer and Metastasis Reviews · doi:10.1023/b:canc.0000031764.81141.e4 · Cited by 153
“It appears that low levels of Mdm2 activity induce monoubiquitination and nuclear export of p53, whereas high levels of Mdm2 promote p53 polyubiquitination and nuclear degradation [66].”
BackgroundInduction of SOX4 by DNA damage is critical for p53 stabilization and function
Pan, X., Zhao, J., Zhang, W.-N., Li, H.-Y., Mu, R., Zhou, T., Zhang, H.-Y., Gong, W.-L., Yu, M., Man, J.-H., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810147106 · Cited by 134
“Because the nuclear exportation of p53 is dependent on its Mdm2-mediated ubiquitination (33), we then tested by immunofluorescence microscopy whether SOX4 blocks the Mdm2mediated p53 nuclear export.”
Methodβ-Arrestin and Mdm2 Mediate IGF-1 Receptor-stimulated ERK Activation and Cell Cycle Progression
Girnita, L., Shenoy, S. K., Sehat, B., Vasilcanu, R., Vasilcanu, D., Girnita, A., Lefkowitz, R. J., & Larsson, O. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611526200 · Cited by 142
Hu, C.-J., Ni, Z., Li, B., Yong, X., Yang, X., Zhang, J.-W., Zhang, D., Qin, Y., Jie, M., Dong, H. F., et al. (2015) · Gut · doi:10.1136/gutjnl-2015-309322 · Cited by 132
Site-specific ubiquitination exposes a linear motif to promote interferon-α receptor endocytosis
Kumar, K. G. S., Barriere, H., Carbone, C. J., Liu, J., Swaminathan, G., Xu, P., Li, Y., Baker, D. P., Peng, J., Lukacs, G. L., et al. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200706034 · Cited by 134
“However, given that ubiquitination is also implicated in regulating other types of protein traffi cking (e.g., in the nuclear export of p53; Li et al., 2003), it is tempting to speculate about a possible interaction between ubiquitination and linear traffi cking signals that might use a similar…”
BackgroundTang, L.-Y., Yamashita, M., Coussens, N. P., Tang, Y., Wang, X., Li, C., Deng, C., Cheng, S. Y., & Zhang, Y. E. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.393 · Cited by 141
“…indicate that E3 ubiquitin ligases can influence macromolecular trafficking to different cellular compartments through mono-ubiquitin modification (Li et al, 2003; Trotman et al, 2007; Dupont et al, 2009), and complexed form The EMBO Journal VOL 30 | NO 23 | 2011 &2011 European Molecular Biology…”
BackgroundTGF-β1–induced expression of human Mdm2 correlates with late-stage metastatic breast cancer
Araki, S., Eitel, J. A., Batuello, C. N., Bijangi-Vishehsaraei, K., Xie, X.-J., Danielpour, D., Pollok, K. E., Boothman, D. A., & Mayo, L. D. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39194 · Cited by 133
Regulation of p53 localization and transcription by the HECT domain E3 ligase WWP1
Laine, A., & Ronai, Z. A. (2006) · Oncogene · doi:10.1038/sj.onc.1209924 · Cited by 133
“The effect of WWP1 is independent of Mdm2 but nevertheless resembles changes after monoubiquitylation of p53 by low levels of Mdm2 (Li et al., 2003).”
BackgroundInfluentialJohnson, T. M., Hammond, E. M., Giaccia, A. J., & Attardi, L. D. (2005) · Nature Genetics · doi:10.1038/ng1498 · Cited by 161
A Novel eIF5A Complex Functions As a Regulator of p53 and p53-dependent Apoptosis
Li, A.-L., Li, H., Jin, B.-F., Ye, Q.-N., Zhou, T., Yu, X.-D., Pan, X., Man, J.-H., He, K., Yu, M., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407165200 · Cited by 131
The roles and regulation of MDM2 and MDMX: it is not just about p53
Klein, A. M., de Queiroz, R. M., Venkatesh, D., & Prives, C. (2021) · Genes & Development · doi:10.1101/gad.347872.120 · Cited by 129
“As described earlier in this review, MDM2 is able to regulate different aspects of its E3 ligase targets, including p53, outside of mere degradation depending on whether it performs polyubiquitylation or monoubiquitylation (Li et al. 2003; Marine and Lozano 2010).”
BackgroundOkamoto, K., Kashima, K., Pereg, Y., Ishida, M., Yamazaki, S., Nota, A., Teunisse, A., Migliorini, D., Kitabayashi, I., Marine, J.-C., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9608-9620.2005 · Cited by 129
“Mdm2 inactivates p53 by promoting its degradation by functioning as an E3 ubiquitin ligase, stimulating its nuclear export, and blocking its transcriptional activity ( 22 , 30).”
BackgroundGotoh, T., Vila-Caballer, M., Santos, C. S., Liu, J., Yang, J., & Finkielstein, C. V. (2014) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-05-0993 · Cited by 146
“…the Mdm2 oncogene protein The Mdm2 protein acts as a bona fide E3-ubiquitin ligase for p53 by binding to its N-terminus and promoting either p53 monoubiquitination and nuclear export or p53 polyubiquitination and degradation through the proteasomal pathway (Honda et al., 1997; Li et al., 2003).”
Banks, D., Wu, M., Higa, L. A., Gavrilova, N., Quan, J., Ye, T., Kobayashi, R., Sun, H., & Zhang, H. (2006) · Cell Cycle · doi:10.4161/cc.5.15.3150 · Cited by 127
Ranked prediction of p53 targets using hidden variable dynamic modeling
Barenco, M., Daniela, T., Brewer, D. S., Callard, R. E., Stark, J., & Hubank, M. J. F. (2006) · Genome biology · doi:10.1186/gb-2006-7-3-r25 · Cited by 145
“This discrepancy can be explained by the operation of other regulatory mechanisms that affect p53 activity but not concentration, for example relocation of phosphorylated p53 to the cytoplasm [25].”
BackgroundThe cytoplasmic side of p53's oncosuppressive activities
Comel, A., Sorrentino, G., Capaci, V., & Del Sal, G. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.04.015 · Cited by 126
“Poly-ubiquitylation of p53 causes its proteasome-mediated degradation, while mono- and multi-mono-ubiquitylation promotes its cytoplasmic relocalization [14,16].”
BackgroundMDM2 and MDMX: Alone and together in regulation of p53.
Shadfan, M., Lopez-Pajares, V., & Yuan, Z.-M. (2012) · PubMed · Cited by 186
Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types
Ge, Z., Leighton, J. S., Wang, Y., Peng, X., Chen, Z., Chen, H., Sun, Y., Yao, F., Li, J., Zhang, H., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.047 · Cited by 125
Mdm2 Induces Mono-Ubiquitination of FOXO4
Brenkman, A. B., de Keizer, P. L. J., van den Broek, N. J. F., Jochemsen, A. G., & Burgering, B. M. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002819 · Cited by 125
“Whereas, initially p53 served as a classical example of a protein regulated through protein degradation, it is by now clear that mono-ubiquitination of p53 occurs and serves to provide a new signaling function to p53 [15,24].”
BackgroundThe phosphorylation of the androgen receptor by TFIIH directs the ubiquitin/proteasome process
Chymkowitch, P., May, N. L., Charneau, P., Compe, E., & Egly, J. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.337 · Cited by 130
“Knowing that MDM2 and CHIP can distinctly monoor polyubiquitinate their substrates (Li et al, 2003, 2007), we also analysed the AR monoubiquitination by replacing His-UbWT by His-UbK0 (a mutated Ubiquitin, with all the lysine residues replaced by alanine).”
BackgroundMethodTargeting SUMO Signaling to Wrestle Cancer
Kroonen, J. S., & Vertegaal, A. C. O. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.11.009 · Cited by 146
Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding
Marchenko, N. D., Hanel, W., Li, D., Becker, K., Reich, N., & Moll, U. M. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.173 · Cited by 123
“On the other hand, proteasome inhibition by ALLN stabilizes p53 mainly in the nucleus of RKO cancer cells, whereas cytoplasmic p53 accumulates to a far lower extent (Figure 1f, top), consistent with earlier reports.(18,23) Surprisingly, however, even in the presence of ALLN, nuclear p53 is largely non-ubiquitinated, i…”
Parkin Regulates the Activity of Pyruvate Kinase M2
Liu, K., Li, F., Han, H., Chen, Y., Mao, Z., Luo, J., Zhao, Y., Zheng, B., Gu, W., & Zhao, W. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.703066 · Cited by 120
“Many proteins can be regulated by monoubiquitylation including histones (45), DNA replication and repair proteins (46, 47), endocytosed receptors and their regulators (48, 49), and p53 (50, 51).”
BackgroundSelf-citationUBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53
Wu, H., Pomeroy, S. L., Ferreira, M., Teider, N., Mariani, J., Nakayama, K. I., Hatakeyama, S., Tron, V. A., Saltibus, L. F., Spyracopoulos, L., et al. (2011) · Nature Medicine · doi:10.1038/nm.2283 · Cited by 120
p53 Degradation by a Coronavirus Papain-like Protease Suppresses Type I Interferon Signaling
Yuan, L., Chen, Z., Song, S., Wang, S., Tian, C., Xing, G., Chen, X., Xiao, Z. J., He, F., & Zhang, L. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.619890 · Cited by 122
A comprehensive method for detecting ubiquitinated substrates using TR-TUBE
Yoshida, Y., Saeki, Y., Murakami, A., Kawawaki, J., Tsuchiya, H., Yoshihara, H., Shindo, M., & Tanaka, K. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422313112 · Cited by 117
“The level of polyubiquitinated p53 was somewhat increased by overexpression of MDM2, whereas monoubiquitinated p53 was present at high levels, suggesting that MDM2 preferentially catalyzes monoubiquitination of p53 under these conditions (19).”
BackgroundKohn, K. W., & Pommier, Y. G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.186 · Cited by 135
Interplay between autophagy and proteasome during protein turnover
Raffeiner, M., Zhu, S., González‐Fuente, M., & Üstün, Ş. (2023) · Trends in Plant Science · doi:10.1016/j.tplants.2023.01.013 · Cited by 131
Wang, F., Marshall, C. B., Yamamoto, K., Li, G., Plevin, M. J., You, H., Mak, T. W., & Ikura, M. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.09.025 · Cited by 124
MdmX Protein Is Essential for Mdm2 Protein-mediated p53 Polyubiquitination
Wang, X., Wang, J., & Jiang, X. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.213868 · Cited by 115
p53 downstream target genes and tumor suppression: a classical view in evolution
Rozan, L. M., & El‐Deiry, W. S. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402058 · Cited by 126
Lim, S. D., Cho, H. Y., Park, Y. C., Ham, D. J., Lee, J. K., & Jang, C. S. (2013) · Journal of Experimental Botany · doi:10.1093/jxb/ert143 · Cited by 122
“When Mdm2 levels are high, Mdm2 drives p53 degradation via polyubiquitination, whereas low levels promote p53 nuclear exclusion via monoubiquitination (Li et al., 2003).”
Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis
Su, D., Ma, S., Shan, L., Wang, Y., Wang, Y., Cao, C., Liu, B., Yang, C., Wang, L., Tian, S., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120518 · Cited by 114
“Moreover, cotransfection of HeLa cells stably expressing FLAG-MDC1 with different amounts of USP7/WT or USP7/C223S together with HA-Ub or a ubiquitin mutant (Ub/mt) with all lysine residues replaced by arginine (50), followed by IP of cellular lysates with anti-FLAG and IB with anti-HA, showed that the levels of ubiqu…”
Regulation of p53 Nuclear Export through Sequential Changes in Conformation and Ubiquitination
Nie, L., Sasaki, M., & Maki, C. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610515200 · Cited by 113
p53-A natural cancer killer: Structural insights and therapeutic concepts
Römer, L., Klein, C., Dehner, A., Kessler, H., & Buchner, J. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200600611 · Cited by 93
Regulators of Oncogenic Mutant TP53 Gain of Function
Yamamoto, S., & Iwakuma, T. (2018) · Cancers · doi:10.3390/cancers11010004 · Cited by 113
“Polyubiquitination of mutp53 leads to its degradation, while its monoubiquitination may alter subcellular localization of mutp53 likewise wtp53 [130,131].”
BackgroundMdm2 and MdmX partner to regulate p53
Wang, X., & Jiang, X. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.02.049 · Cited by 111
Targeting nucleocytoplasmic transport in cancer therapy
Hill, R., Cautain, B., de Pedro, N., & Link, W. (2013) · Oncotarget · doi:10.18632/oncotarget.1457 · Cited by 129
“While polyubiquitinated p53 is targeted for proteasomal degradation, mono-ubiquitinated p53 is specifically targeted for nuclear export [33;34] and directly contributes to the cellular choice between cell cycle arrest, senescence or apoptosis.”
BackgroundE6-associated protein (E6-AP) is a dual function coactivator of steroid hormone receptors
Ramamoorthy, S., & Nawaz, Z. (2008) · Nuclear Receptor Signaling · doi:10.1621/nrs.06006 · Cited by 109
“In addition to E6-AP, a variety of other E3-ligases have also been shown to promote p53 degradation including Mdm2 (murine double minute 2), COP1 (constitutively photomorphogenic 1), PIRH2 (p53-induced-RING-H2), etc [Dornan et al., 2004; Leng et al., 2003; Li et al., 2003].”
Molecular functions of NEDD4 E3 ubiquitin ligases in cancer
Zou, X., Levy‐Cohen, G., & Blank, M. (2015) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.06.005 · Cited by 110
Bitomsky, N., & Hofmann, T. G. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07331.x · Cited by 125
Regulation of p53 - insights into a complex process
Boehme, K. A., & Blattner, C. (2009) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409230903401507 · Cited by 105
Restoration of p53 to limit tumor growth
Wang, W., & El-Deiry, W. S. (2008) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3282f31d6f · Cited by 104
Constant p53 Pathway Inactivation in a Large Series of Soft Tissue Sarcomas with Complex Genetics
Pérot, G., Chibon, F., Montero, A., Lagarde, P., de Thé, H., Terrier, P., Guillou, L., Ranchère‐Vince, D., Coindre, J., & Aurias, A. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100104 · Cited by 116
NM23-H1 Tumor Suppressor and Its Interacting Partner STRAP Activate p53 Function
Jung, H., Seong, H., & Ha, H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705181200 · Cited by 105
Chrisanthar, R., Knappskog, S., Løkkevik, E., Anker, G. B., Østenstad, B., Lundgren, S., Risberg, T., Mjaaland, I., Skjønsberg, G., Aas, T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019249 · Cited by 115
“mutations. MDM2 plays a key role regulating p53 function through direct binding, ubiquitination and degradation”
BackgroundTakayama, K.-I., Suzuki, T., Fujimura, T., Takahashi, S., & Inoue, S. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0471 · Cited by 104
Regulation of the protein stability of EMT transcription factors
Díaz, V., Viñas-Castells, R., & García de Herreros, A. (2014) · Cell Adhesion & Migration · doi:10.4161/19336918.2014.969998 · Cited by 104
“The main role of Mdm2 consists in the ubiquitination and degradation of the tumor suppressor p53, which prevents cancer progression by inhibition of proliferation and induction of apoptosis.(103,104) Curiously, p53 can antagonize the action of the EMT transcription factor Snail2 by forming a p53-Snail2Mdm2 complex tha…”
BackgroundAmato, R., D’Antona, L., Porciatti, G., Agosti, V., Menniti, M., Rinaldo, C., Costa, N., Bellacchio, E., Mattarocci, S., Fuiano, G., et al. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0525-5 · Cited by 103
“The protein can be inactivated by ubiquitylation [20, 21].”
Backgroundp53-mediated autophagic regulation: A prospective strategy for cancer therapy
Tang, J., Di, J., Cao, H., Bai, J., & Zheng, J. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.014 · Cited by 111
“These modifications include acetylation, methylation, phosphorylation, and ubiquitination, which could integrate multiple stress signals andmodulate its activity [21–23].”
BackgroundUbiquitination of mammalian AP endonuclease (APE1) regulated by the p53-MDM2 signaling pathway
Busso, C. S., Iwakuma, T., & Izumi, T. (2009) · Oncogene · doi:10.1038/onc.2009.5 · Cited by 100
PTEN regulates RPA1 and protects DNA replication forks
Wang, G., Li, Y., Wang, P., Liang, H., Cui, M., Zhu, M., Guo, L., Su, Q. P., Sun, Y., McNutt, M. A., et al. (2015) · Cell Research · doi:10.1038/cr.2015.115 · Cited by 107
Regulation of p53 tetramerization and nuclear export by ARC
Foo, R. S.-Y., Nam, Y.-J., Ostreicher, M. J., Metzl, M. D., Whelan, R. S., Peng, C.-F., Ashton, A. W., Fu, W., Mani, K., Chin, S.-F., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710017104 · Cited by 102
Yang, W.-L., Zhang, X., & Lin, H.-K. (2010) · Oncogene · doi:10.1038/onc.2010.190 · Cited by 115
“Mdm2 is previously known to be an E3 ligase for p53 and promotes p53 nuclear export and degradation (Li et al., 2003).”
Pluquet, O., Qu, L.-K., Baltzis, D., & Koromilas, A. E. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.21.9392-9405.2005 · Cited by 101
Regulation of p53 Localization and Activity by Ubc13
Laine, A., Topisirovic, I., Zhai, D., Reed, J. C., Borden, K. L. B., & Ronai, Z. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01156-06 · Cited by 100
“The latter is consistent with earlier studies in which it was necessary to utilize a linear fusion of ubiquitin and p53 to demonstrate that monoubiquitinated p53 is exported from the nucleus to the cytoplasm ( 23 ).”
BackgroundInfluentialChen, Z. Y., Wang, X., Zhou, Y., Offner, G., & Tseng, C.-C. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2059 · Cited by 100
MSL2 Promotes Mdm2-independent Cytoplasmic Localization of p53
Kruse, J.-P., & Gu, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m805658200 · Cited by 100
Self-citationRegulation of the p53 transcriptional activity
Liu, G., & Chen, X. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20700 · Cited by 100
“The monoubiquitination is sufficient for p53 nuclear export, but not for p53 degradation by 26S proteosome [Li et al., 2003; Yang et al., 2004].”
BackgroundA coming-of-age story: activation-induced cytidine deaminase turns 10
Delker, R. K., Fugmann, S. D., & Papavasiliou, F. N. (2009) · Nature Immunology · doi:10.1038/ni.1799 · Cited by 98
Ubiquitin charging of human class III ubiquitin-conjugating enzymes triggers their nuclear import
Plafker, S. M., Plafker, K. S., Weissman, A. M., & Macara, I. G. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200406001 · Cited by 97
“A complementary function for Ub in nuclear export has recently been reported in studies analyzing the functional consequence of p53 mono-ubiquitylation by Mdm2 (Li et al., 2003).”
BackgroundRogulski, K. R., Li, Y., Rothermund, K. D., Pu, L., Watkins, S. C., Yi, F., & Prochownik, E. V. (2005) · Oncogene · doi:10.1038/sj.onc.1208897 · Cited by 103
“The subsequent fate and function of Mdm2 is likely to be depend on its level and may involve monoubiquitination of p53 and its nuclear-to-cytoplasmic shuttling, or p53 polyubiquitination and nuclear degradation (Mayo and Donner, 2001; Li et al., 2003a).”
BackgroundInfluentialCell fate regulation governed by p53: Friends or reversible foes in cancer therapy
Song, B., Yang, P., & Zhang, S. (2024) · 癌症:英文版 · doi:10.1002/cac2.12520 · Cited by 109
Jab1 Induces the Cytoplasmic Localization and Degradation of p53 in Coordination with Hdm2
Oh, W., Lee, E., Sung, Y. H., Yang, M.-R., Ghim, J., Lee, H., & Song, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601857200 · Cited by 102
Roles of ubiquitin signaling in transcription regulation
Hammond-Martel, I., Yu, H., & Affar, E. B. (2011) · Cellular Signalling · doi:10.1016/j.cellsig.2011.10.009 · Cited by 110
Cul4A Physically Associates with MDM2 and Participates in the Proteolysis of p53
Nag, A., Bagchi, S., & Raychaudhuri, P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2598 · Cited by 94
“MDM2 preferably generates monoubiquitinated p53 (18).”
Jin, J.-Z., Lin, G., Huang, H., Xu, D. M., Yu, H., Ma, X., Zhu, L., Ma, D., & Jiang, H. (2014) · International Journal of Biological Sciences · doi:10.7150/ijbs.7730 · Cited by 99
“Monoubiquitylation might act as a signal of nuclear export for p53, and the different levels of MDM2 could induce both mono- or poly-ubiquitination in a dose-dependent manner and determine the fate of p53 [19].”
Back to your heart: Ubiquitin proteasome system-regulated signal transduction
Portbury, A. L., Ronnebaum, S. M., Zungu, M., Patterson, C., & Willis, M. S. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.10.023 · Cited by 94
“Monoubiquitination targets p53 for nuclear export in a dosedependent manner [87,88].”
Dynamic ubiquitination determines transcriptional activity of the plant immune coactivator NPR1
Skelly, M. J., Furniss, J. J., Grey, H., Wong, K.-W., & Spoel, S. H. (2019) · eLife · doi:10.7554/elife.47005 · Cited by 98
“Progression to the polyubiquitinated form of p53 in the nucleus is carried out by the U-box E4 ligase UBE4B that interacts with both MDM2 and p53 (Li et al., 2003; Wu and Leng, 2011; Wu et al., 2011).”
BackgroundGotoh, T., Kim, J. K., Liu, J., Vila-Caballer, M., Stauffer, P. E., Tyson, J. J., & Finkielstein, C. V. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607984113 · Cited by 103
“3B, Upper; t1/2n/t1/2c ∼ 7 times) where p53 is normally polyubiquitinated and targeted for degradation (30).”
BackgroundThe prolyl-isomerase Pin1 activates the mitochondrial death program of p53
Sorrentino, G., Mioni, M., Giorgi, C., Ruggeri, N., Pinton, P., Moll, U., Mantovani, F., & Del Sal, G. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.112 · Cited by 89
“It is well known that by promoting p53 prolyl-isomerization, Pin1 lowers its affinity for HDM2 (8), and that low cellular levels of HDM2 favor p53 monoubiquitination and mitochondrial translocation.(3,36) Moreover, it has been shown that Pin1 inhibition results in decreased p53 monoubiquitination in favor of polyubiqu…”
BackgroundPhylogeny of the TRAF/MATH Domain
Zapata, J. M., Martínez-García, V., & Lefebvre, S. (2007) · Springer eBooks · doi:10.1007/978-0-387-70630-6_1 · Cited by 103
The Multiple Layers of Ubiquitin-Dependent Cell Cycle Control
Wickliffe, K. E., Williamson, A. P., Jin, L., & Rapé, M. (2009) · Chemical Reviews · doi:10.1021/cr800414e · Cited by 104
XIAP Monoubiquitylates Groucho/TLE to Promote Canonical Wnt Signaling
Hanson, A. J., Wallace, H. A., Freeman, T. J., Beauchamp, R. D., Lee, L. A., & Lee, E. N. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.12.032 · Cited by 99
“Recent studies have shown a role for monoubiquitylation in regulating the subcellular localization of transcription factors olecular Cell 45, 619–628, March 9, 2012 ª2012 Elsevier Inc. 623 (Dupont et al., 2009; Li et al., 2003; van der Horst et al., 2006).”
Delineating Crosstalk Mechanisms of the Ubiquitin Proteasome System That Regulate Apoptosis
Gupta, I., Singh, K., Varshney, N. K., & Khan, S. M. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00011 · Cited by 93
“Low levels of MDM2 monoubiquitinates p53 while a high-level leads to its polyubiquitination (Li et al., 2003; Figure 6).”
BackgroundGannon, H. S., Donehower, L. A., Lyle, S., & Jones, S. N. (2011) · Developmental Biology · doi:10.1016/j.ydbio.2011.02.007 · Cited by 87
“Furthermore, Mdm2 can function as an E3 ligase to ubiquitinate p53 (Honda et al., 1997) and induce p53 degradation in the 26S proteasome (Haupt et al., 1997; Kubbutat et al., 1997; Li et al., 2003).”
BackgroundStommel, J. M., & Wahl, G. M. (2005) · Cell Cycle · doi:10.4161/cc.4.3.1522 · Cited by 87
Ubiquitin–proteasome system as a modulator of cell fate
Thompson, S. J., Loftus, L. T., Ashley, M. D., & Meller, R. (2007) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.09.010 · Cited by 94
Jeay, S., Ferretti, S., Holzer, P., Fuchs, J., Chapeau, E. A., Wartmann, M., Sterker, D., Romanet, V., Murakami, M., Kerr, G., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0338 · Cited by 87
Small-molecule inhibitors of MDM2 as new anticancer therapeutics
Dickens, M. P., Fitzgerald, R. P., & Fischer, P. M. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.10.003 · Cited by 97
A non-canonical role for a small nucleolar RNA in ribosome biogenesis and senescence
Cheng, Y., Wang, S., Zhang, H., Lee, J.-S., Ni, C., Guo, J., Chen, E., Wang, S., Acharya, A., Chang, T.-C., et al. (2024) · Cell · doi:10.1016/j.cell.2024.06.019 · Cited by 98
Su, W., Fang, J., Cheng, F., Liu, C., Zhou, F., & Zhang, J. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211604110 · Cited by 92
“Various E3 ligases regulate p53 activity through direct degradation, changes in subcellular localization, or the alteration of transcription activity (3, 10, 12).”
BackgroundSmall molecule agents targeting the p53‐MDM2 pathway for cancer therapy
Wang, W., & Hu, Y. (2012) · Medicinal Research Reviews · doi:10.1002/med.20236 · Cited by 85
“Low level of MDM2 activity induces mono-ubiquitination and transports p53 from the nucleus to cytoplasm, while high level promotes poly-ubiquitination and degradates p53 through proteasomal pathway.(101) A number of studies have verified that using cellular proteins such as ARF and several small ribosomal proteins cou…”
BackgroundGu, H.-Y., Wang, X., Rao, S., Wang, J., Zhao, J., Ren, F. L., Mu, R., Yang, Y., Qi, Q., Liu, W., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0212 · Cited by 84
REGγ modulates p53 activity by regulating its cellular localization
Liu, J., Yu, G., Zhao, Y., Zhao, D., Wang, Y., Wang, L., Liu, J., Li, L., Zeng, Y., Dang, Y., et al. (2010) · Journal of Cell Science · doi:10.1242/jcs.067405 · Cited by 91
“Jo ur na l o f C el l S ci en ce Jo ur na l o f C el l S ci en ce reported to drive its relocation to the cytoplasm (Li et al., 2003).”
Background
Metadata
- Authors
- Li, M., Brooks, C. L., Wu-Baer, F., Chen, D., Baer, R., & Gu, W.
- Affiliations
- Columbia University (US)
- Corresponding author
- Gu, Wei
- Venue
- Science
- Published
- 2003-12-12
- Volume
- 302
- Issue
- 5652
- Pages
- 1972-1975
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2050745715
- Cited by
- 804
- References
- 30
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 21 · 2023: 21 · 2022: 24 · 2021: 25 · 2020: 28 · 2019: 22 · 2018: 22 · 2017: 24 · 2016: 32 · 2015: 34 · 2014: 45 · 2013: 37 · 2012: 38
- FWCI
- 19.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Keywords
- p53, MDM2, monoubiquitination, polyubiquitination, ubiquitination, p53 degradation, tumor suppressor regulation
- MeSH terms
- Animals, Cell Nucleus, Cells, Cultured, Cytoplasm, Humans, Mutation, Nuclear Proteins, Proto-Oncogene Proteins, Recombinant Fusion Proteins, Transfection, Tumor Suppressor Protein p53, Mice, Knockout, Protein Transport, Active Transport, Cell Nucleus, Ubiquitin, Cell Line, Tumor, Mice, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.